Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study
Rongchang Chen1, Wenjiang Ma2, Xuezhong Yu3, Xinmin Liu4, Jihong Zhu5, Hong Liang6, Xiaomei Wu7, Tao Guo81State Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, China; 2Respiratory Department, The First Affiliated Hospital of Medical School of Zhejian...
Main Authors: | Chen R, Ma W, Yu X, Liu X, Zhu J, Liang H, Wu X, Guo T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-04-01
|
Series: | International Journal of General Medicine |
Online Access: | http://www.dovepress.com/intravenous-moxifloxacin-in-routine-hospital-treatment-of-respiratory--a7121 |
Similar Items
-
Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of  chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study
by: Yulin Feng, et al.
Published: (2010-03-01) -
Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection
by: Fumitaka Ito, et al.
Published: (2016-02-01) -
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)
by: Xiang Wang, et al.
Published: (2020-03-01) -
Safety and tolerability of moxifloxacin in the treatment of respiratory tract infections: a post-marketing surveillance conducted in Indonesia
by: Arini Setiawati, et al.
Published: (2005-02-01) -
Disposition kinetics of long acting moxifloxacin following intravenous administration in Sheep
by: Chirag M. Modi, et al.
Published: (2012-01-01)